共查询到20条相似文献,搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
Roz Laing Taisei Kikuchi Axel Martinelli Isheng J Tsai Robin N Beech Elizabeth Redman Nancy Holroyd David J Bartley Helen Beasley Collette Britton David Curran Eileen Devaney Aude Gilabert Martin Hunt Frank Jackson Stephanie L Johnston Ivan Kryukov Keyu Li Alison A Morrison Adam J Reid Neil Sargison Gary I Saunders James D Wasmuth Adrian Wolstenholme Matthew Berriman John S Gilleard James A Cotton 《Genome biology》2013,14(8):R88
7.
8.
9.
The genome and developmental transcriptome of the strongylid nematode Haemonchus contortus 总被引:1,自引:0,他引:1
Erich M Schwarz Pasi K Korhonen Bronwyn E Campbell Neil D Young Aaron R Jex Abdul Jabbar Ross S Hall Alinda Mondal Adina C Howe Jason Pell Andreas Hofmann Peter R Boag Xing-Quan Zhu T Ryan Gregory Alex Loukas Brian A Williams Igor Antoshechkin C Titus Brown Paul W Sternberg Robin B Gasser 《Genome biology》2013,14(8):R89
10.
11.
12.
13.
14.
15.
Ercole Mazzeo Laura Rubino Michela Buglione Paolo Antognoni Stefano Maria Magrini Francesco Bertoni Manuela Parmiggiani Paola Barbieri Filippo Bertoni 《Reports of Practical Oncology and Radiotherapy》2014,19(2):77-91
Aim
To evaluate the current treatment of mycosis fungoides (MF) and Sézary syndrome (SS) focusing on the role of radiotherapy (RT), its principles and indications, and the perspectives of the novel irradiation technologies.Background
MF and SS are rare lymphoproliferative diseases whose incidence is increasing. For a long time RT has been used as a single modality or in integrated treatment programs for these diseases.Materials and methods
The latest systematic reviews, primary studies and new diagnostic and treatment guidelines on MF and SS were analyzed. Clinical outcomes together with the technical aspects and the role of RT were also evaluated.Results
New data are available on pathogenesis, diagnostic criteria, classification and staging procedures for MF and SS and several local and systemic therapies are proposed. Localized RT can cure “minimal stage” MF while total skin electron beam irradiation (TSEI) may cure initial-stage disease and may offer important symptom relief (itch, erythroderma) in a more advanced setting. Despite its efficacy, RT is not largely used, mainly because of some technical difficulties but new RT technologies may be proposed to treat large skin surfaces.Conclusions
New treatment programs offer good results, with median survival of more than 12 years in early-stage MF, but the median survival of 2.5 years or less in advanced stages is still a challenge. RT remains an option for all stages with a good cost/effectiveness ratio in a curative or palliative setting. New RT technologies can overcome some technical problems of treating large skin surfaces. 相似文献16.
17.
18.
19.